University of Calgary
Calgary, AB, Canada
Dr. May Choi is a rheumatologist and Associate Professor at the Cumming School of Medicine, University of Calgary. She is also the Associate Director of Mitogen Advanced Diagnostics Laboratory and Director of the AI.Dx Laboratories. Dr. Choi's current research interests are focused on biomarker discovery and validation for prediction of clinical outcomes systemic autoimmune rheumatic diseases. She completed a Lupus Fellowship at the Brigham and Women's Hospital and MPH at Harvard University.
Friday, October 24, 2025
4:10 PM - 4:30 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
4:30 PM - 4:50 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
4:50 PM - 5:10 PM Central Time
Disclosure information not submitted.
Friday, October 24, 2025
5:10 PM - 5:30 PM Central Time
Disclosure information not submitted.
Sunday, October 26, 2025
9:00 AM - 10:30 AM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
27M31: Rheumatology Research Foundation Memorial Lecture: To Memoralize Dr. Eng Tan
Monday, October 27, 2025
10:30 AM - 11:30 AM Central Time
Disclosure information not submitted.
27M46: Bench to Bedside in the Diagnosis and Treatment of Lupus Nephritis
Monday, October 27, 2025
1:00 PM - 2:30 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
2414: Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development
Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
28T43: Getting to the Heart of the Issue: Perimyocarditis in Autoimmune Diseases
Tuesday, October 28, 2025
1:00 PM - 2:00 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
IT28T4: The Intersection Where Rheumatology Meets Dermatology (TBC)
Tuesday, October 28, 2025
1:30 PM - 2:15 PM Central Time
Disclosure information not submitted.
28T52: Prevention Is the Best Medicine: Updates for Rheumatoid Arthritis and Lupus
Tuesday, October 28, 2025
2:30 PM - 4:00 PM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
